4.0 Article

Complex Subtype Diversity of HIV-1 Among Drug Users in Major Kenyan Cities

Journal

AIDS RESEARCH AND HUMAN RETROVIRUSES
Volume 33, Issue 5, Pages 500-510

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/aid.2016.0321

Keywords

drug users; HIV-1 subtypes; intersubtype recombinants; Kenya

Funding

  1. South African Research Chairs Initiative
  2. Victor Daitz Foundation
  3. International Early Career Scientist award from the Howard Hughes Medical Institute
  4. DELTAS Africa Initiative [107752/Z/15/Z]
  5. African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA)
  6. New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency)
  7. Wellcome Trust [107752/Z/15/Z]
  8. UK Government
  9. South African Medical Research Council (MRC)
  10. IAS/NIDA
  11. Wellcome Trust [107752/Z/15/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

Drug users are increasingly recognized as a key population driving human immunodeficiency virus (HIV) spread in sub-Saharan Africa. To determine HIV-1 subtypes circulating in this population group and explore possible geographic differences, we analyzed HIV-1 sequences among drug users from Nairobi, Mombasa, and Kisumu in Kenya. Wesequenced gag and env from 55 drug users. Subtype analysis from 220 gag clonal sequences from 54 of 55 participants (median = 4/participant) showed that 44.4% were A, 16.7% were C, 3.7% were D, and 35.2% were intersubtype recombinants. Of 156 env clonal sequences from 48 of 55 subjects (median = 3/participant), 45.8% were subtype A, 14.6% were C, 6.3% were D, and 33.3% were recombinants. Comparative analysis of both genes showed that 30 (63.8%) participants had concordant subtypes, while 17 (36.2%) were discordant. We identified one genetically linked transmission pair and two cases of dual infection. These data are indicative of extensive HIV-1 intersubtype recombination in Kenya and suggest decline in subtype D prevalence.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available